Synergy Pharmaceuticals Files NDA for Plecanatide in Chronic Idiopathic Constipation

NEW YORK, January 29, 2016 -- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company has filed with the U.S. Food and Drug Administration (FDA) its first new drug application (NDA) for plecanatide in chronic idiopathic constipation...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news